Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2017-08-23 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share cancellations and repurchases, references to Listing Rules of the Hong Kong Stock Exchange, and confirms compliance with repurchase regulations. The content focuses on share capital changes and share buyback disclosures, which aligns with announcements regarding share repurchases or capital changes rather than a full financial report or other types of filings. Therefore, the document fits the category of Transaction in Own Shares (POS). The document length and detail confirm it is not a brief announcement but a substantive disclosure of share transactions.
2017-08-23 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from PW Medtech Group Limited regarding the date of a board meeting to approve the unaudited consolidated interim results for the six months ended 30 June 2017 and to consider the payment of an interim dividend. It does not contain the actual interim financial results or detailed financial data, but rather informs about the upcoming board meeting and the intention to publish the interim results. The document length is only 1392 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing or intention to publish a report are classified as Report Publication Announcements (RPA).
2017-08-17 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for PW Medtech Group Limited. It includes details about the meeting date, location, agenda (approval of a proposed spin-off and share issuance), proxy appointment instructions, and shareholder eligibility for voting. There are no financial statements, management discussion, or detailed financial data present. The document is an announcement informing shareholders about the meeting and the resolutions to be considered, not the results or minutes of the meeting. It is not a full report or financial filing but a formal meeting notice. Therefore, the appropriate classification is a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2017-08-08 English
Form of Proxy for use at the Extraordinary General Meeting to be held on Tuesday, August 29, 2017
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of PW Medtech Group Limited. It includes instructions for shareholders to appoint a proxy to vote on resolutions related to a proposed spin-off and share issuance. The content is procedural and related to voting arrangements for a shareholder meeting, not a report or announcement of financial results or corporate changes. It is not a report itself but a proxy form for voting at a meeting. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2017-08-08 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF TIANXINFU (BEIJING) MEDICAL APPLIANCE CO., LTD. ON THE A SHARE STOCK EXCHANGE AND DEEMED DISPOSAL AND MAJOR TRANSACTION
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from PW Medtech Group Limited regarding a proposed spin-off and separate listing of a subsidiary on the A Share Stock Exchange, including details about a deemed disposal and major transaction. It includes letters from the Board, Independent Board Committee, and Independent Financial Adviser, financial information appendices, and a notice of an Extraordinary General Meeting (EGM) to approve the transaction. The document is comprehensive and intended to inform shareholders about the transaction and solicit their approval at the EGM. This type of document is typically classified as a Proxy Solicitation & Information Statement (PSI), as it provides detailed information to shareholders to enable informed voting on corporate actions at a meeting. It is not merely an announcement or a brief notice, nor is it a full annual or interim report, earnings release, or other categories. Therefore, the appropriate classification is PSI with high confidence.
2017-08-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/07/2017 and submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content focuses exclusively on share capital changes and movements during the month, without any financial performance data, earnings, or management discussion. It is a regulatory filing reporting share capital movements to the exchange rather than a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a compliance document reporting share capital movements to the exchange.
2017-08-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.